Ceramide Activated Protein Phosphatases
神经酰胺激活蛋白磷酸酶
基本信息
- 批准号:10434893
- 负责人:
- 金额:$ 35.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-12 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAddressAdhesionsApoptosisBasic ScienceBiochemicalBiologicalCell AdhesionCell CompartmentationCell Cycle RegulationCell DeathCell membraneCell physiologyCellsCeramidesCessation of lifeCoupledDevelopmentElementsEnzymesEventFamilyGenerationsGoalsGrowthHumanHydroxylationIn VitroLipidsMediatingMembraneMetabolismMolecularNaturePathway interactionsPhosphoric Monoester HydrolasesProductionProtein DephosphorylationProtein Phosphatase 2A Regulatory Subunit PR53Protein phosphataseProteinsRegulationRoleSchemeSignal PathwaySpecificitySphingolipidsSphingomyelinaseStimulusTNF geneTimebiological adaptation to stresscancer cellcell growthcell growth regulationcell motilitycombinatorialdimerezrinliquid chromatography mass spectrometrymigrationnovelprogramsprototyperadixin proteinresponsesenescencestemtargeted cancer therapytumor progression
项目摘要
Ceramide constitutes a family of closely related molecules that function as
bioeffector lipids with roles in the regulation of stress responses and growth/death of
various human cancer cells. Critical missing elements in our understanding of ceramide
stems from the lack of molecularly-defined targets of action and from defining
compartment-specific functions of ceramides. Studies in our lab supported by this project
have identified ceramide-activated Ser–Thr phosphatases (CAPPs), specifically PP1 and
PP2A as direct targets activated by ceramide in vitro. Studies in cells have also shown
that various ceramide-inducing stimuli (e.g. TNF, UV, lipotoxic agents) induce
dephosphorylation of several substrates in a ceramide-dependent manner. However, not
all stimuli induce all dephosphorylations, presumably due to their activation of distinct
pathways in distinct subcellular compartments. Recent results have provided us a
breakthrough in defining a specific pathway of ceramide generation at the plasma
membrane (PM). Here, we will investigate the hypothesis that ceramide generated at
the PM acutely activates PP1cα that leads to the dephosphorylation of ezrin and other
proteins. This results in a compartment-specific role for ceramide in regulating cell
adhesion and migration. We will address these aims: Aim 1. Define a novel pathway of
ceramide generation at the PM leading to ezrin dephosphorylation though activation of
PP1cα. Here we will investigate the specific hypothesis that PM ceramide regulates a
specific form of dimeric PP1c to mediate ezrin dephosphorylation, independent of raft
formation. Aim 2. Identify specific cellular programs coupled to compartmentalized
ceramide/CAPPs. Here we will investigate the specific hypothesis that PM ceramide,
in contrast to ceramide formed in other compartments, regulates cell adhesion and
migration. Taken together, these approaches should result, for the first time, in clearly
defining a specific, direct, and relevant target for ceramide action (PP1) with a specific
function in mediating the effects of PM ceramide on cell adhesion and migration.
神经酰胺组成了一个密切相关的分子家族,其功能是
生物效应脂在应激反应和细胞生长/死亡调节中的作用
各种人类癌细胞。我们对神经酰胺认识中的关键缺失元素
源于缺乏分子上定义的作用靶点和定义
神经酰胺的隔室特有功能。由该项目支持的实验室研究
已发现神经酰胺激活的丝氨酸苏氨酸磷酸酶(CAPP),特别是PP1和
PP2A作为神经酰胺体外激活的直接靶点。对细胞的研究也表明
神经酰胺诱导的各种刺激(如肿瘤坏死因子、紫外线、脂毒剂)诱导
几种底物以神经酰胺依赖的方式去磷酸化。然而,不是
所有刺激诱导所有去磷酸化,可能是由于它们激活了不同的
在不同的亚细胞室中的通路。最近的结果为我们提供了一个
在确定血浆中神经酰胺生成的特定途径方面取得突破
膜(PM)。在这里,我们将调查神经酰胺产生于
PM敏锐地激活PP1cα,导致Ezrin和其他
蛋白质。这导致神经酰胺在调节细胞中具有隔室特异性作用。
黏附和迁移。我们将解决这些目标:目标1.定义一条新的途径
PM中神经酰胺的生成通过激活Ezrin去磷酸化
PP1cα。在这里,我们将调查PM神经酰胺调节A
不依赖RAFT的二聚体PP1c介导Ezrin去磷酸化的特定形式
队形。目标2.确定与分区相结合的特定蜂窝程序
神经酰胺/CAPPS。在这里,我们将调查PM神经酰胺,
与其他隔室中形成的神经酰胺不同,神经酰胺调节细胞黏附和
迁移。综上所述,这些方法应该第一次产生明确的
为神经酰胺作用(PP1)定义特定的、直接的和相关的靶点
PM神经酰胺在介导细胞黏附和迁移中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YUSUF AWNI HANNUN其他文献
YUSUF AWNI HANNUN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YUSUF AWNI HANNUN', 18)}}的其他基金
Protein kinase C in Lung Cancer with mutant EGFR
EGFR 突变肺癌中的蛋白激酶 C
- 批准号:
10618917 - 财政年份:2020
- 资助金额:
$ 35.76万 - 项目类别:
Protein kinase C in Lung Cancer with mutant EGFR
EGFR 突变肺癌中的蛋白激酶 C
- 批准号:
10454776 - 财政年份:2020
- 资助金额:
$ 35.76万 - 项目类别:
Protein kinase C in Lung Cancer with mutant EGFR
EGFR 突变肺癌中的蛋白激酶 C
- 批准号:
9888660 - 财政年份:2020
- 资助金额:
$ 35.76万 - 项目类别:
Neutral Sphingomyelinases and Bioactive Ceramides
中性鞘磷脂酶和生物活性神经酰胺
- 批准号:
10437811 - 财政年份:2016
- 资助金额:
$ 35.76万 - 项目类别:
Neutral Sphingomyelinases and Bioactive Ceramides
中性鞘磷脂酶和生物活性神经酰胺
- 批准号:
10640899 - 财政年份:2016
- 资助金额:
$ 35.76万 - 项目类别:
Neutral sphingomyelinases and bioactive ceramides
中性鞘磷脂酶和生物活性神经酰胺
- 批准号:
9071506 - 财政年份:2016
- 资助金额:
$ 35.76万 - 项目类别:
Diversity Supplement for Bernandie Jean: Neutral sphingomyelinases and bioactive ceramides
Bernandie Jean 的多样性补充:中性鞘磷脂酶和生物活性神经酰胺
- 批准号:
9752140 - 财政年份:2016
- 资助金额:
$ 35.76万 - 项目类别:
Admin Supplement: Neutral Sphingomyelinases and Bioactive Ceramides
管理补充剂:中性鞘磷脂酶和生物活性神经酰胺
- 批准号:
10797322 - 财政年份:2016
- 资助金额:
$ 35.76万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 35.76万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 35.76万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 35.76万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 35.76万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 35.76万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 35.76万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 35.76万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 35.76万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 35.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 35.76万 - 项目类别:
Operating Grants














{{item.name}}会员




